Wolverine Trading, LLC Cyclacel Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$1.23 - $21.9 $15,006 - $267,180
12,200 New
12,200 $16,000
Q4 2021

Feb 14, 2022
SELL
$6.04 - $8.03 $73,688 - $97,965
-12,200 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$8.02 - $11.0 $97,844 - $134,200
12,200 New
12,200 $69,000

About Cyclacel Pharmaceuticals, Inc.

CYCC Quotes by TradingView
  • Ticker CYCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,539,200
  • Market Cap $4.64M
  • Description
  • Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...
More about CYCC
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email